GD2-TARGETING CAR-NK CELLS ENHANCED BY TRANSGENIC GITRL EXPRESSION ARE AN EFFECTIVE FOR GLIOBLASTOMA AND MELANOMA

被引：0
|
作者：
Tirapelle, M. C. [1 ,2 ]
Schmidt, D. D. [1 ,2 ]
Ebrahimabadi, S. [1 ,2 ]
Covas, D. [3 ]
Picanco-Castro, V. [4 ]
机构：
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil
[2] Hemoctr Ribeirao Preto, Ribeirao Preto, Brazil
[3] Fundacao Hemoctr Ribeirao Preto, Ribeirao Preto, Brazil
[4] Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil
来源：
CYTOTHERAPY | 2024年 / 26卷 / 06期
基金：
巴西圣保罗研究基金会;
关键词：
NK cells; GD2; solid tumor;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1010
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 30 条
  • [1] GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
    Gargett, Tessa
    Ebert, Lisa M.
    Truong, Nga T. H.
    Kollis, Paris M.
    Sedivakova, Kristyna
    Yu, Wenbo
    Yeo, Erica C. F.
    Wittwer, Nicole L.
    Gliddon, Briony L.
    Tea, Melinda N.
    Ormsby, Rebecca
    Poonnoose, Santosh
    Nowicki, Jake
    Vittorio, Orazio
    Ziegler, David S.
    Pitson, Stuart M.
    Brown, Michael P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [2] GENERATION OF CAR-NK CELLS ANTI-GD2 CO-EXPRESSING GITRL IN TUMOR MODELS OF NEUROECTODERMAL ORIGIN
    Tirapelle, M. C.
    Schmidt, D.
    Ebrahimabadi, S.
    Silvestre, R. N.
    Covas, D. T.
    Picanco e Castro, V.
    CYTOTHERAPY, 2022, 24 (10) : S20 - S20
  • [3] Assessing the cytotoxic potential of novel CAR-NK cells targeting glioblastoma stem cell antigens
    Lima, Vitoria A.
    Mitsugi, Thiago G.
    Okamoto, Oswaldo K.
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [4] TARGETING GLIOBLASTOMA & DIFFUSE INTRINSIC PONTINE GLIOMA W/ANTI-GD2 CAR MODIFIED NK CELLS
    Aggarwal, Payal
    Luo, Wen
    Pehlivan, Katherine
    Hoang, Hai
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S5 - S6
  • [5] Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma
    Thul, S.
    Reindl, L. M.
    Wendel, P.
    Burger, M. C.
    Steinbach, J. P.
    Wels, W. S.
    KLINISCHE PADIATRIE, 2024, 236 (03): : 215 - 215
  • [6] CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment
    Christodoulou, Ilias
    Rahnama, Ruyan
    Ravich, Wesley J.
    Seo, Jaesung
    Zolov, Sergey
    Marple, Andrew
    Markovitz, David M.
    Bonifant, Challice L.
    BLOOD, 2021, 138
  • [7] Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK
    Weihua Liu
    Yu Zhao
    Zhongfeng Liu
    Guangji Zhang
    Huantong Wu
    Xin Zheng
    Xihe Tang
    Zhiguo Chen
    Cellular Oncology, 2023, 46 : 1747 - 1762
  • [8] Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK
    Liu, Weihua
    Zhao, Yu
    Liu, Zhongfeng
    Zhang, Guangji
    Wu, Huantong
    Zheng, Xin
    Tang, Xihe
    Chen, Zhiguo
    CELLULAR ONCOLOGY, 2023, 46 (06) : 1747 - 1762
  • [9] GD2-TARGETING CAR T CELLS SHOW PROMISE IN H3K27M-MUTATED GLIOMAS
    不详
    CANCER DISCOVERY, 2022, 12 (04) : 882 - 882
  • [10] CAR-NK Cells for Immunotherapy of Solid Tumors: Mediating Effective Non-Viral Genetic Engineering of NKG2D-Reprogrammed NK Cells
    Wang, Jiao
    MOLECULAR THERAPY, 2018, 26 (05) : 341 - 341
123